| 000 | 01748 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250515211601.0 | ||
| 264 | 0 | _c20100325 | |
| 008 | 201003s 0 0 eng d | ||
| 022 | _a0172-6390 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMihăilă, Romeo | |
| 245 | 0 | 0 |
_aLovastatin and fluvastatin reduce viremia and the pro-inflammatory cytokines in the patients with chronic hepatitis C. _h[electronic resource] |
| 260 |
_bHepato-gastroenterology _c |
||
| 300 |
_a1704-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAlanine Transaminase _xblood |
| 650 | 0 | 4 |
_aAspartate Aminotransferases _xblood |
| 650 | 0 | 4 |
_aCytokines _xblood |
| 650 | 0 | 4 | _aEchocardiography |
| 650 | 0 | 4 |
_aFatty Acids, Monounsaturated _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFluvastatin |
| 650 | 0 | 4 |
_aHepatitis C, Chronic _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aIndoles _xtherapeutic use |
| 650 | 0 | 4 |
_aInterleukin-10 _xblood |
| 650 | 0 | 4 |
_aInterleukin-8 _xblood |
| 650 | 0 | 4 |
_aLovastatin _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xblood |
| 650 | 0 | 4 |
_aViremia _xdrug therapy |
| 700 | 1 | _aNedelcu, Laurentiu | |
| 700 | 1 | _aFrăţilă, Ovidiu | |
| 700 | 1 | _aRezi, Elena Cristina | |
| 700 | 1 | _aDomnariu, Carmen | |
| 700 | 1 | _aCiucă, Ramona | |
| 700 | 1 | _aZaharie, Alina Viorica | |
| 700 | 1 | _aOlteanu, Ariela | |
| 700 | 1 | _aBera, Liliana | |
| 700 | 1 | _aDeac, Mircea | |
| 700 | 1 | _aMihăilă, Rodica | |
| 773 | 0 |
_tHepato-gastroenterology _gvol. 56 _gno. 96 _gp. 1704-9 |
|
| 999 |
_c19581239 _d19581239 |
||